Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma
Language English Country United States Media print-electronic
Document type Comparative Study, Journal Article
PubMed
27492457
DOI
10.1007/s13277-016-5274-9
PII: 10.1007/s13277-016-5274-9
Knihovny.cz E-resources
- Keywords
- Fibroblast activation protein α, Glioma, Seprase, Serine protease, Stromal cells,
- MeSH
- Apoptosis MeSH
- Stromal Cells metabolism pathology MeSH
- Adult MeSH
- Endopeptidases MeSH
- Fibroblasts metabolism pathology MeSH
- Glioblastoma genetics metabolism pathology MeSH
- Immunoenzyme Techniques MeSH
- Real-Time Polymerase Chain Reaction MeSH
- Middle Aged MeSH
- Humans MeSH
- Membrane Proteins genetics metabolism MeSH
- RNA, Messenger genetics MeSH
- Mesoderm metabolism pathology MeSH
- Survival Rate MeSH
- Mice, Inbred NOD MeSH
- Mice MeSH
- Biomarkers, Tumor metabolism MeSH
- Tumor Cells, Cultured MeSH
- Follow-Up Studies MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- Prognosis MeSH
- Cell Proliferation MeSH
- Aged MeSH
- Serine Endopeptidases genetics metabolism MeSH
- Neoplasm Staging MeSH
- Case-Control Studies MeSH
- Cell Line, Transformed metabolism pathology MeSH
- Blotting, Western MeSH
- Xenograft Model Antitumor Assays MeSH
- Gelatinases genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Aged MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Endopeptidases MeSH
- fibroblast activation protein alpha MeSH Browser
- Membrane Proteins MeSH
- RNA, Messenger MeSH
- Biomarkers, Tumor MeSH
- Serine Endopeptidases MeSH
- Gelatinases MeSH
Glioblastomas are deadly neoplasms resistant to current treatment modalities. Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies. FAP is considered a potential therapeutic target and is associated with a worse patient outcome in some cancers. The FAP localization in the glioma microenvironment and its relation to patient survival are unknown. By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level. FAP expression was most elevated in the mesenchymal subtype of glioblastoma. It was neither associated with glioblastoma patient survival in our patient cohort nor in publicly available datasets. FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers. In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP. Endogenous FAP was frequently upregulated and part of the FAP+ host cells coexpressed the CXCR4 chemokine receptor. In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth. The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.
Department of Neurosurgery Na Homolce Hospital Roentgenova 2 150 30 Prague 5 Czech Republic
Department of Pathology Na Homolce Hospital Roentgenova 2 150 30 Prague 5 Czech Republic
See more in PubMed
World J Stem Cells. 2014 Apr 26;6(2):134-43 PubMed
Int Rev Cell Mol Biol. 2012;297:83-116 PubMed
Int J Cancer. 2016 Feb 15;138(4):1013-23 PubMed
Br J Haematol. 2008 Sep;142(5):827-30 PubMed
Am J Pathol. 2007 May;170(5):1445-53 PubMed
Exp Mol Pathol. 2013 Aug;95(1):105-10 PubMed
Cancer Res. 2005 Dec 1;65(23):11156-63 PubMed
Thromb Haemost. 2003 Mar;89(3):561-72 PubMed
Int J Biochem Cell Biol. 2012 May;44(5):738-47 PubMed
Cancer Res. 2015 Jul 15;75(14 ):2800-2810 PubMed
J Clin Invest. 2009 Dec;119(12):3613-25 PubMed
Mol Oncol. 2016 Jan;10 (1):40-58 PubMed
J Pathol. 2014 May;233(1):74-88 PubMed
Cancer Immunol Res. 2014 Feb;2(2):121-6 PubMed
Onkologie. 2003 Feb;26(1):44-8 PubMed
Cancer Cell. 2006 Mar;9(3):157-73 PubMed
Cell Stem Cell. 2009 Jun 5;4(6):568-80 PubMed
Clin Exp Metastasis. 2011 Aug;28(6):567-79 PubMed
Cancer Biol Ther. 2007 Nov;6(11):1691-9 PubMed
Cancer Genomics Proteomics. 2011 May-Jun;8(3):139-47 PubMed
Lab Invest. 2004 Apr;84(4):397-405 PubMed
BMC Cancer. 2011 Jun 13;11:245 PubMed
BMB Rep. 2013 May;46(5):252-7 PubMed
Nat Rev Immunol. 2011 Jun;11(6):427-35 PubMed
Int J Cancer. 1994 Sep 15;58(6):841-6 PubMed
Front Biosci. 2008 Jan 01;13:2319-26 PubMed
Tumour Biol. 2015 Aug;36(8):5873-9 PubMed
PLoS One. 2015 Mar 16;10(3):e0116683 PubMed
Am J Pathol. 2008 May;172(5):1381-90 PubMed
Proteomics Clin Appl. 2014 Jun;8(5-6):454-63 PubMed
Int J Biochem Cell Biol. 2004 Jun;36(6):1046-69 PubMed
Cancer Res. 2004 Apr 15;64(8):2712-6 PubMed
Brain Pathol. 1999 Jul;9(3):469-79 PubMed
Biol Chem. 2011 Mar;392(3):199-207 PubMed
Science. 2010 Nov 5;330(6005):827-30 PubMed
Int J Oncol. 2007 Oct;31(4):785-92 PubMed
J Pathol. 2011 Jun;224(2):222-33 PubMed
Nat Protoc. 2009;4(1):44-57 PubMed
Curr Mol Med. 2012 Dec;12(10):1220-43 PubMed
Glia. 2011 Aug;59(8):1169-80 PubMed
Hum Pathol. 2013 Nov;44(11):2549-57 PubMed
Cancer Cell. 2010 Jan 19;17(1):98-110 PubMed
Cancer Res. 2009 Dec 1;69(23):9065-72 PubMed
Folia Neuropathol. 2012;50(4):301-21 PubMed
Clin Cancer Res. 2012 Nov 15;18(22):6208-18 PubMed
J Thromb Haemost. 2011 May;9(5):987-96 PubMed
Prostate. 2016 Jun;76(8):703-14 PubMed
Histochem Cell Biol. 2015 May;143(5):497-504 PubMed
Cancer Immunol Res. 2014 Feb;2(2):154-66 PubMed
Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4 PubMed
Cell Death Dis. 2014 Apr 10;5:e1155 PubMed
Mol Cancer. 2010 Jul 20;9:194 PubMed
Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis